drugset / Trial / NCT04249336

Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH

NCT04249336

Phase 3 Completed 140 enrolled Dow University of Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

This will be multi-centered, triple blinded, randomized, four parallel treatments assigned study to compare clinical efficacy of commercially available dentifrices with placebo for immediate and sustained relief from Dentin Hypersensitivity after short term use. Condition or disease: Dentin hypersensitivity Intervention/Treatment: Product 1; Fluoro-Calcium-Phospho-silicate based BioMin F Product 2; Pro-Argin formula based Colgate Sensitive Pro-Relief Product 3; Strontium Acetate based Sensodyne Rapid Action Product 4; Sodium Fluoride based Colgate Total

Timeline

Start
2019-09-27
Primary completion
2021-01-16
Completion
2021-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoro-Calcium-Phospho-Silicate Unknown Topical
Comparator L-arginine Small molecule 8 % Topical
Comparator Strontium Acetate Unknown 8 % Topical
Comparator sodium fluoride Unknown Topical

Indications